Cargando…
A study of ovarian cancer patients treated with dose-intensive chemotherapy supported with peripheral blood progenitor cells mobilised by filgrastim and cyclophosphamide.
We have shown that large numbers of haemopoietic progenitor cells are mobilised into the blood after filgrastim [granulocyte colony-stimulating factor (G-CSF)] alone and filgrastim following cyclophosphamide chemotherapy in previously untreated patients with ovarian cancer. These cells may be used t...
Autores principales: | Weaver, A., Wrigley, E., Watson, A., Chang, J., Collins, C. D., Jenkins, B., Gill, C., Pettengell, R., Dexter, T. M., Testa, N. G., Crowther, D. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2077231/ https://www.ncbi.nlm.nih.gov/pubmed/8956800 |
Ejemplares similares
-
Recombinant human granulocyte colony-stimulating factor (filgrastim) following high-dose chemotherapy and peripheral blood progenitor cell rescue in high-grade non-Hodgkin's lymphoma: clinical benefits at no extra cost.
por: Lee, S. M., et al.
Publicado: (1998) -
Prior chemotherapy does not prevent effective mobilisation by G-CSF of peripheral blood progenitor cells.
por: DeLuca, E., et al.
Publicado: (1992) -
Filgrastim, lenograstim and pegfilgrastim in the mobilization of peripheral blood progenitor cells in patients with lymphoproliferative malignancies
por: Ria, Roberto, et al.
Publicado: (2014) -
Plerixafor Salvage Is Safe and Effective in Hard-to-Mobilize Patients Undergoing Chemotherapy and Filgrastim-Based Peripheral Blood Progenitor Cell Mobilization
por: Awan, Farrukh T., et al.
Publicado: (2012) -
Filgrastim fails to improve haemopoietic reconstitution following myeloablative chemotherapy and peripheral blood stem cell rescue.
por: Dunlop, D. J., et al.
Publicado: (1994)